Non-Hodgkin Lymphoma by Clinical Course

Non-Hodgkin Lymphoma by Clinical Course — Trials · CancerIndex

Clinical trials

Registered studies

1,200 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 346
Recruiting: 173
Ph III recruiting: 8
Growth YoY: +32.7%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (209)

clinicaltrialsPublishedShowing 51–67 of 67 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04775745	Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.	recruiting	Phase 1	60	Newave Pharmaceutical IncINDUSTRY	1	Feb 13, 2026	clinicaltrials
NCT05544019	Study of SGR-1505 in Mature B-Cell Neoplasms	recruiting	Phase 1	98	Schrödinger, Inc.INDUSTRY	8	Feb 13, 2026	clinicaltrials
NCT06191887